These findings prompted us to study whether KCNE1 D85N would also modify the QT interval and/or the clinical picture in patients with genetically homogeneous forms of LQTS in which the variability caused by the disease-causing mutation itself can be controlled for. This evidence concerns the gene KCNE1 and familial long QT syndrome.